Macrophage migration inhibitory factor (MIF) is essential for Type 2 effector cell immunity to an intestinal helminth parasite by Filbey, Kara J. et al.
This is a repository copy of Macrophage migration inhibitory factor (MIF) is essential for 
Type 2 effector cell immunity to an intestinal helminth parasite.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/151231/
Version: Accepted Version
Article:
Filbey, Kara J., Varyani, Fumi, Harcus, Yvonne et al. (8 more authors) (Accepted: 2019) 
Macrophage migration inhibitory factor (MIF) is essential for Type 2 effector cell immunity 
to an intestinal helminth parasite. Frontiers in immunology. ISSN 1664-3224 (In Press) 
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
  
 
Macrophage migration inhibitory factor
(MIF) is essential for Type 2 effector cell
immunity to an intestinal helminth
parasite
 
Kara Filbey1,  Fumi Varyani1,  Yvonne Harcus1,  James Hewitson1,  Danielle Smyth2,  Henry
Mcsor ley3,  Alasdair Ivens1,  Susanne Nylén4,  Mart in Rot t enberg4,  Stephan Löser2,  Rick M.
Maizels5*
 
1Inst it ut e of  Immunology and Infect ion Research,  Universit y of  Edinburgh,  Unit ed Kingdom, 2Wellcome
Cent re for Int egrat ive Parasit ology,  Universit y of  Glasgow,  Unit ed Kingdom,  3Cent re for Inf lammat ion
Research,  Universit y of  Edinburgh,  Unit ed Kingdom,  4Microbiology,  Tumor and Cell Biology,  Karolinska
Inst it ute (KI),  Sweden, 5Wellcome Cent re for Int egrat ive Parasit ology,  Inst it ut e of  Infect ion,  Immunit y
and Inf lammat ion,  Universit y of  Glasgow,  Unit ed Kingdom
 Submit t ed t o Journal:
 
Front iers in Immunology
 Specialt y Sect ion:
 
Cyt okines and Soluble Mediat ors in Immunit y
 Art icle type:
 
Original  Research Art icle
 Manuscript  ID:
 
470753
 Received on:
 
07 May 2019
 Revised on:
 
08 Aug 2019
 Front iers websit e link:
 www. f ront iersin. org
In r vi
ew
  
 
Conflict  of interest  statement
 The authors declare that  the research was conducted in the absence of any commercial or financial
relat ionships that  could be construed as a potential conflict  of interest
  
 
Author contribut ion statement
 
KJF,  FV,  YH, and SL designed and undert ook t he maj orit y of  experiments;  JPH, DJS,  HMS, SN and MR undert ook special ized
experiment s;  AI provided guidance on t he design of  and analysed t he RNA array experiment ;  and RMM oversaw al l  work and wrot e
the paper.
  
 
Keywords
 
Arginase 1 (Arg-1),  helmint h,  macrophage,  Innat e immnuit y,  eosinophil
  
 
Abstract
Word count : 255
 
Immunit y t o int est inal  helmint hs is known t o require bot h innat e and adapt ive component s of  t he immune syst em act ivat ed along
t he Type 2 IL-4R/ STAT6-dependent  pat hway.  We have found t hat  macrophage migrat ion inhibit ory fact or (MIF) is essent ial  for t he
development  of  ef fect ive immunit y t o t he int est inal helmint h Hel igmosomoides polygyrus,  even fol lowing vaccinat ion which induces
st eri le immunit y in wild-t ype mice.  A chemical inhibit or of  MIF,  4-IPP,  was similarly found t o compromise ant i-parasit e immunit y.
Cel lular analyses found t hat  t he adapt ive arm of  t he immune response,  including IgG1 ant ibody responses and Th2-derived
cyt okines,  was int act  and t hat  Foxp3+ T regulat ory cel l  responses were unal t ered in t he absence of  MIF.  However,  MIF was found t o
be an essent ial  cyt okine for innat e cel ls,  wit h ablat ed eosinophil ia and ILC2 responses,  and delayed recruit ment  and act ivat ion of
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macrophage def icit  was also seen in wild-t ype BALB/ c mice exposed t o 4-IPP.  Gene expression analysis of  int est inal and lymph node
t issues f rom MIF-def icient  and -suf f icient  infected mice indicated signif icant ly reduced levels of  Arl2bp,  encoding a factor involved in
nuclear local izat ion of  STAT3. We furt her found that  STAT3-def icient  macrophages expressed less Arginase-1,  and t hat  mice lacking
STAT3 in t he myeloid compartment  (LysMCrexSTAT3f l / f l ) were unable t o rej ect  a secondary infect ion wit h H.  polygyrus.  We t hus
conclude t hat  in t he cont ext  of  a Type 2 infect ion,  MIF plays a crit ical  role in polarizing macrophages int o t he prot ect ive
al t ernat ively-act ivat ed phenot ype,  and t hat  STAT3 signal ing may make a previously unrecognized cont ribut ion t o immunit y t o
helminths.
  
 
Contribut ion to the field
Our work est abl ishes for t he f i rst  t ime t he cri t ical  role in t ype 2 immunit y for MIF,  macrophage migrat ion inhibi t ory fact or.  As
described in t he manuscript ,  t his is a long-st anding member of  t he immunological  repert oire,  having been discovered in 1966.
Whi le i t s role in t ype 1 inf lammat ion was recorded in earl ier work,  we now show i t  is a player essent ial  for t ype 2 ef fect or
responses,  using a helminth infect ion model.  We use MIF-def icient  mice,  and conf irm wit h a pharmacological inhibit or of  MIF,  t hat  i t
is required for al t ernat ive act ivat ion of  (M2) macrophages,  and t heir t imely expression of  t he key mediat or Arginase-1.  Gene
expression analysis revealed an unexpect ed l ink wit h STAT3,  as MIF-def icient  mice also had marked reduct ion in a prot ein report ed
to extend nuclear local izat ion of  t his factor.  We therefore t ested mice in which STAT3 is condit ionally deleted in myeloid cel ls,
showing a reduct ion in Arginase-1 responses and an inabi l i t y t o express funct ional  ant i-helmint h immunit y when chal lenged in a
secondary infect ion model.  We bel ieve t his manuscript  wil l  be of  wide int erest  in i t s broadening of  t he Type 2 molecular family,
bot h wit h respect  t o MIF it sel f ,  and also t he involvement  of  t he STAT3 pat hway.  The work is also t imely,  wit h t he role of  t he
canonical IL-4/ IL-13 pat hway comprehensively underst ood,  but  t he many addit ional modif iers and checkpoint s of  t ype 2 act ivat ion
yet  t o be charact erized.
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Abstract 19 
Immunity to intestinal helminths is known to require both innate and adaptive components of the 20 
immune system activated along the Type 2 IL-4R/STAT6-dependent pathway. We have found 21 
that macrophage migration inhibitory factor (MIF) is essential for the development of effective 22 
immunity to the intestinal helminth Heligmosomoides polygyrus, even following vaccination 23 
which induces sterile immunity in wild-type mice. A chemical inhibitor of MIF, 4-IPP, was 24 
similarly found to compromise anti-parasite immunity. Cellular analyses found that the adaptive 25 
arm of the immune response, including IgG1 antibody responses and Th2-derived cytokines, was 26 
intact and that Foxp3
+
 T regulatory cell responses were unaltered in the absence of MIF. 27 
However, MIF was found to be an essential cytokine for innate cells, with ablated eosinophilia 28 
and ILC2 responses, and delayed recruitment and activation of macrophages to the M2 29 
phenotype (expressing Arginase 1, Chil3, and RΕLM-α) upon infection of MIF-deficient mice; a 30 
macrophage deficit was also seen in wild-type BALB/c mice exposed to 4-IPP. Gene expression 31 
analysis of intestinal and lymph node tissues from MIF-deficient and -sufficient infected mice 32 
indicated significantly reduced levels of Arl2bp, encoding a factor involved in nuclear 33 
localization of STAT3. We further found that STAT3-deficient macrophages expressed less 34 
Arginase-1, and that mice lacking STAT3 in the myeloid compartment (LysM
Cre
xSTAT3
fl/fl
) 35 
were unable to reject a secondary infection with H. polygyrus. We thus conclude that in the 36 
context of a Type 2 infection, MIF plays a critical role in polarizing macrophages into the 37 
protective alternatively-activated phenotype, and that STAT3 signaling may make a previously 38 
unrecognized contribution to immunity to helminths. 39 
  40 
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Introduction 41 
Intestinal helminths constitute the most prevalent group of parasites in the human population 42 
today, with around 1.5 billion people infected throughout the tropical and sub-tropical zones of 43 
the globe [1; 2]. While drugs are available that temporarily clear intestinal parasites, therapy does 44 
not confer immunity to re-infection. Strategies aiming to boost the immune system through 45 
vaccination are constrained by a lack of understanding of basic mechanisms of resistance to 46 
infection, including the relative roles of innate and adaptive immunity in expelling parasites [3]. 47 
Thus, while CD4
+
 T cells are essential drivers of anti-helminth immunity, parasite expulsion 48 
requires activation of innate effector cell populations [4; 5]. In the case of the mouse model 49 
parasite Heligmosomoides polygyrus, the most critical effector is likely to be the alternatively 50 
activated (M2) macrophage induced through T-cell derived IL-4/-13 [6; 7].  Signaling through 51 
the IL-4Rα subunit is essential for M2 activation, and is known to require STAT6 activation and 52 
nuclear translocation [8; 9]. However, the role of other STAT factors in immunity to helminths 53 
has been little explored [10]. 54 
We now identify a key player in immunity to H. polygyrus to be macrophage migration 55 
inhibitory factor (MIF), as mice genetically deficient in this protein, or exposed to 56 
pharmacological inhibitors of MIF, are unable to expel intestinal worms normally. Although MIF 57 
has been classically associated with type 1 inflammation during microbial exposure and sepsis 58 
[11; 12], more recent studies have also identified a role for this molecule in development of Th2 59 
responsiveness to allergens [13; 14]. It has also been reported that antibody-mediated 60 
neutralization of MIF in vivo increases the burden of Schistosoma japonicum worms in the 61 
tissues of infected mice [15].  In addition, we and others have found that M2 activation of 62 
macrophages by IL-4 is amplified in the presence of MIF [16; 17]. We therefore decided to test 63 
the role of MIF in chronic infection with H. polygyrus. 64 
As described below, MIF-deficient animals show delayed infiltration and activation across a 65 
broad range of innate immune cell populations, including macrophages, type 2 innate lymphoid 66 
cells (ILC2s) and eosinophils. Gene array analyses of infected tissues pointed to a relatively 67 
circumscribed shift in expression profile which included sharply reduced levels of Arl2bp, a 68 
promoter of STAT3 function. Mice lacking STAT3 in their myeloid compartment were found to 69 
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phenocopy the MIF-deficient mice in failing to reject a challenge infection of H. polygyrus.  70 
Hence, MIF is an essential mediator in the activation of the innate compartment for 71 
immunological clearance of parasitic helminths from the gastrointestinal tract, in a manner 72 
dependent at least in part upon signaling through STAT3. 73 
  74 
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Materials and Methods 75 
Mice and Parasites 76 
BALB/c and MIF-deficient mice on the BALB/c background [18] were bred in-house and 77 
housed in individually-ventilated cages (IVCs) according to UK Home Office guidelines. Mice 78 
on the C57BL/6 background expressing Cre recombinase under the LysM promoter [19], and 79 
carrying flanking loxP (flox) sites either side of the Stat3 locus, were bred as described 80 
previously [20]. 81 
Infections employed 200 L3 larvae of H. polygyrus in 200 µl water by oral gavage. Parasite 82 
lifecycles and collection of HES products were conducted as previously described in 83 
CBAxC57BL/6 F1 mice [21]. Granuloma and adult worm counts were conducted after small 84 
intestines were removed and sliced longitudinally. 3-4 fecal pellets were weighed and dissolved 85 
in 2 ml dH20; 2 ml of saturated salt solution (400 g NaCl in 1 L dH20) was then added and eggs 86 
enumerated using a McMaster egg counting chamber. Egg counts are represented as eggs/g fecal 87 
material. For secondary infections, mice were cleared of worms after infection with H. polygyrus 88 
with pyrantel embonate Strongid-P paste (Elanco Animal Health), given in 2 doses of 2.5 mg 89 
dissolved in 200 µl dH20 given on days 28 and 29 by oral gavage. After 2 weeks, mice were re-90 
infected with 200 L3 larvae. 91 
In vivo administrations 92 
1 mg of MIF inhibitor, 4-IPP (Tocris Bioscience #3249) [22] dissolved in DMSO, or DMSO 93 
alone, was administered intraperitoneally in 50 µl every other day, during H. polygyrus infection 94 
(adapted from [17]). 50 ng of recombinant MIF (R&D) in 50 µl PBS, or PBS alone, was 95 
administered i.p. every other day, during H. polygyrus infection. rIL-33 (R&D) was administered 96 
intranasally (200 ng in 50 µl PBS) to sedated mice on days 0, 1 and 2, and lung tissue taken at 97 
day 3 for analysis. Alternaria alternata antigen (Greer) was administered intranasally (10 µg in 98 
50 µl PBS) to sedated mice.  BALF was harvested 1 hour later (adapted from [23].  For 99 
vaccination, mice were immunized with 5 µg of HES intraperitoneally in alum adjuvant, and 100 
boosted on days 28 and 35 with 1 µg in alum before challenge with H. polygyrus at day 42 [24].   101 
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Cell isolation and culture  102 
MLN cell suspensions were prepared directly by passage through 70 µm nylon filters (BD) and 103 
placed in RPMI1640 (Gibco) containing 10% FCS, 1% PenStrep (Gibco) and 1% L-glutamine 104 
(Gibco)(complete RPMI). Cells were restimulated for 72 hours at 37¡C with either media alone 105 
or HES at a final concentration of 1 µg/ml with 1x10
6
 cells, in triplicate. Peritoneal exudate cells 106 
were collected by washing the peritoneal cavity with 2 x 5 ml RPMI1640 using a 23 gauge 107 
needle. Red blood cells were removed by adding 3 ml red blood cell (RBC) lysis buffer (Sigma) 108 
for 4 minutes, and washing with complete RPMI. Peritoneal lavage used for ELISA analysis 109 
consisted of the supernatant from the first 5 ml wash following centrifugation to pellet cells. 110 
Bronchoalveloar lavage was collected by washing the lungs with 1 ml ice-cold PBS. Lung tissue 111 
was digested in HBSS (Gibco) supplemented with 4U/ml Liberase TL (Roche) and 160 U/ml 112 
DNAse 1 (Sigma). Tissue was incubated at 37¡C for 25 mins, passed through 70 µm nylon filters 113 
(BD) and RBC-lysed before cells were used for flow cytometric analysis.  114 
Flow cytometry  115 
Cells were stained in 96-well round-bottomed plates. Prior to antibody staining, cells were 116 
washed in PBS and stained with LIVE/DEAD Fixable Blue (Invitrogen) at a 1/1000 dilution in 117 
100 µl PBS for 20 min at 4¡C. Then, Fc receptors were blocked in 50 µl of FACS buffer 118 
containing 100 µg/ml of nave rat IgG (Sigma) for 20 min at 4¡C. Samples were then surface 119 
stained for 20 min in 20 µl of FACS buffer containing a combination of the antibodies detailed 120 
below. Lineage markers for ILC2 negative gating: CD3 (Biolegend 17A2), CD4 (Biolegend 121 
RM4-5), CD8α (Biolegend 53-6.7), CD19 (Biolegend 6D5) CD49b (eBioscience DX5), Gr1 122 
(Biolegend RB6-8C5), CD11c (Biolegend N418); ICOS (eBiosceince 15F9), F4/80 (Biolegend 123 
BM8), CD11b (Biolegend M1/70), SiglecF (BD E50-2440). To measure intracellular IL-5, cells 124 
were first stimulated for 4 hrs at 37¡C in the presence of PMA (50 ng/ml), Ionomycin (1 µg/ml), 125 
and Brefeldin A (10 µg/ml) (all from Sigma). Following surface staining, cells were 126 
permeabilised for 30 min at 4¡C in Cytofix/Cytoperm solution (BD), and then washed twice in 127 
200 µl of Perm/Wash (BD). ILC2s were stained for intracellular cytokine expression in 128 
Perm/Wash (BD) using anti-IL-5 (eBioscience TRFK5). For Foxp3 (eBioscience, FJK-16s), 129 
Arginase-1 (R&D Systems IC5868P), RELM-α (R&D Systems 226033, labeled with AF647 130 
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(Invitrogen)) and Chil3 (R&D biotinylated goat anti-mouse combined with Streptavidin PeCy7 131 
(Biolegend)), samples were stained for surface markers after which cells were permeabilised for 132 
12 hrs at 4¡C in Fix/Perm solution (eBioscience Foxp3 staining set), and then washed twice in 133 
200 µl of Perm/Wash (eBioscience Foxp3 staining set). After staining, cells were washed twice 134 
in 200 µl of FACS buffer before acquisition on the LSR II or Canto flow cytometers (BD 135 
Bioscience) and subsequently analysed using FlowJo (Tree Star). 136 
Cytokine ELISAs  137 
Cytokine levels were detected in culture supernatants and BALF by ELISA using monoclonal 138 
capture and biotinylated detection antibody pairs as follows, used at concentrations optimised 139 
previously: IL-4 (11B11 + BVD6-24G2 (BD Pharmingen)); IL-13 (eBio13A + eBio1316H 140 
(eBioscience)); IL-33 (R&D Duoset).  p-nitrophenyl phosphate (pNPP, 1 mg/ml, Sigma) was 141 
used as a substrate. OD was measured at 405 nm on a Precision microplate reader (Molecular 142 
Devices) and data analysed using Softmax Pro software. 143 
Antibody ELISAs  144 
Serum antibodies to HES were measured by ELISA as previously described [7]. Briefly, plates 145 
were coated with 1 µg/ml HES in carbonate buffer, blocked with 10% BSA in carbonate buffer, 146 
and incubated with serial dilutions of sera.  Antibody binding was detected using HRP-147 
conjugated goat anti-mouse IgA or IgG1 (Southern Biotech 1070-50 and 1040-50) and ABTS 148 
Peroxidase Substrate (KPL), and read at 405 nm.  149 
Gut homogenate  150 
Approx. 1 cm small intestine was homogenised in 500 µl 1x lysis buffer (Cell Signalling 151 
Technology Inc) plus 5 µl phenylmethanesulfonyl fluoride solution (PMSF) (Sigma) using a 152 
TissueLyser (Qiagen). Samples were centrifuged at 12,000 rpm for 10 mins to remove debris and 153 
supernatants added to ELISAs, at a 1:10 dilution, to measure RELM-α (Peprotech) and Chil3 154 
(R&D).  Levels were normalised to total protein content measured using a Bradford assay.  The 155 
same ELISA sets were used to analyse peritoneal lavage levels of RELM-α and Chi3.   156 
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Immunohistochemistry  157 
Transverse sections were made from 2 cm of paraffin-embedded small intestine, at a thickness of 158 
4 µm using a cryostat. For MIF staining, sections were deparaffinised by immersing slides in 159 
Histoclear (Brunel Microscopes Ltd) for 5 mins, and then hydrated through 100%, 95% and 70% 160 
ethanol successively. Antigen retrieval was undertaken with citrate buffer (20 mM citric acid + 161 
0.05% Tween 20 at pH6) warmed to 95¡C for 20 mins. Sections were blocked in 1x PBS with 162 
1% BSA, 2% normal rabbit serum, 0.1% Triton X-100 and 0.05% Tween 20 for 30 mins at room 163 
temperature and then incubated with rabbit α-MIF (Invitrogen) at 1:2000 dilution in block buffer, 164 
and left overnight at 4¡C. Slides were immersed in 3% H2O2 for 10 mins at room temperature, 165 
and washed in PBS. Goat α-rabbit conjugated to biotin (Vector Laboratories) at 5 µg/ml in PBS 166 
was added for 1 hour at room temperature, in the dark. Following 2 washes in PBS, several drops 167 
of ABC Vectastain (Vector Laboratories) were added and slides left for 30 mins at room 168 
temperature, in the dark. Slides were washed twice in PBS and DAB peroxidase solution (Vector 169 
Laboratories) was added for 5 mins (until a brown stain had developed). With water washes in 170 
between, the following were added successively to counterstain the sections: Harris hemotoxylin 171 
solution (Sigma), acid alcohol (75% ethanol + 1% HCl) and ScottÕs Tap Water Substitute 172 
(ddH2O + 42 mM NaHCO3 and 167 mM MgSO4). Slides were dehydrated through 75%, 95% 173 
and 100% ethanol and then Histoclear added for 5 mins. Coverslips were added with DPX 174 
mountant (Sigma) and slides were left to dry overnight, in the dark. Pictures were taken using a 175 
Leica DFC290 compound microscope and Leica Application Suite software. 176 
For fluorescent staining of macrophages, proximal small intestinal tissue was harvested and 177 
longitudinally opened. Any food matter was then gently removed by scraping and the tissue 178 
rolled onto a toothpick. Tissue was immediately immersed in OCT compound (Tissue-Tek), 179 
frozen on dry ice and stored at -80¡C. Then, 13 µm thick sections were cut using a cryotome 180 
(Thermo Fisher), attached to positively charged microscope slides (VWR), dried for 15 min at 181 
room temperature and then stored at -80¡C. For the staining procedure, tissue sections were 182 
thawed at room temperature and dried for 15 min under airflow, followed by fixation with 4% 183 
paraformaldehyde in PBS for 15 min at room temperature. The sections were then rinsed twice in 184 
PBS, permeabilised in PBS/0.1% saponin (Sigma-Aldrich) and consecutively blocked using a 185 
solution of 10% donkey serum (Abcam) and 0.3M glycine (Fisher Scientific) in PBS for 60 min 186 
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at room temperature. After 2 washes in PBS/0.1% saponin, primary staining was performed 187 
overnight at 4¡C in PBS/1%BSA/0.1% saponin containing an antibody cocktail of: rat anti-188 
mouse CD68-FITC (FA-11, Biolegend used at 5ug/mL), rat anti-mouse EpCam-PE (G8.8, 189 
Biolegend, 2.5ug/mL) and sheep anti-human/mouse arginase 1 (R&D, 5ug/mL). Stained tissue 190 
sections were then washed 3 times in PBS/0.1% saponin and secondary antibody staining was 191 
performed with donkey anti-sheep AF647 (Abcam, 1/500) for 40 min at room temperature. This 192 
was followed by 3 washes in PBS/0.1% saponin and 2 PBS washes. DAPI containing 193 
Vectashield mounting media (Vector) and coverslips were applied prior to imaging using an 194 
EVOS FL Auto 2 fluorescence microscope (Invitrogen). Mean fluorescence intensity (MFI) of 195 
Arginase-1 staining in granulomas was analysed using the image analysis software Fiji (SciJava). 196 
RNA extraction and quantitative PCR  197 
To isolate mRNA from MLN and duodenal tissue, samples were first immersed in 1 ml of Trizol 198 
(Invitrogen) and disrupted using a TissueLyser (Qiagen) for 2 min at 25Hz and then stored at -199 
80¡C until mRNA isolation was performed with the Qiagen mRNA easy kit (Qiagen) according 200 
to manufacturerÕs instructions.  For duodenal analysis, approx. 0.5 cm of the uppermost part of 201 
the duodenum was sampled. Briefly, tissue was first disrupted using a TissueLyser (Qiagen), 202 
then 200 µl chloroform was added and samples were centrifuged at 12,000 g for 15 min at 4¡C. 203 
The upper aqueous layer was recovered and added to 500 µl of isopropanol, mixed, and stood at 204 
room temperature for 10 min. The sample was then centrifuged again at 12,000 g for 10 min at 205 
4¡C. Pelleted RNA was washed once in 70% ethanol, and allowed to air dry before being 206 
dissolved in 50 µl of DEPC-treated water; 15 µl RNA was treated with DNAse (DNAFree kit, 207 
Ambion), concentrations were determined using a Nanodrop 1000 (Thermo Scientific), and 208 
samples reverse-transcribed using 1-2 µg of RNA with M-MLV reverse transcriptase (Promega). 209 
A PCR block (Peltier Thermal Cycler, MJ Research) was used for the transcription reaction at 210 
37¡C for 60 min. Gene transcript levels were measured by real-time PCR on a Roche Lightcycler 211 
480 II, in 10 µl total volume made up of 4 µl cDNA, 5 µl SYBR Green (Roche), 0.3 µl of each 212 
primer (10 µM), and 0.4 µl DEPC treated water (Ambion) using standard conditions for 60 213 
cycles. Target gene expression levels were normalised against the housekeeping gene GAPDH.  214 
Primer sequences were as follows: 215 
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ARL2BP ADP-ribosylation factor-like binding protein 216 
F: CGTATCCCAGGCTTCAACA 217 
R: TGTGAGCAGCATGTCAAAGA 218 
PHC2 Polyhomeotic 2  219 
F: CCC ACA AAA TGG AAT GTA GAG G 220 
R: ACT CCT CCG CGA TCT CCT: 221 
Array and analysis  222 
Two independent array experiments were conducted; in one, wild type BALB/c or MIF-deficient 223 
mice were infected with H. polygyrus for 5 days with tissues from the duodenum and MLN 224 
being collected and stored in RNA Later (Ambion) prior to processing. Duodenal tissues from 225 
uninfected BALB/c and MIF-deficient mice were also taken and stored (4 mice per group for 226 
each condition). MLNs from uninfected mice were too small to include in this experiment. In the 227 
second experiment, duodenal tissues were taken from naive mice (day 0) as well as days 3 and 7 228 
of H. polygyrus infection for both BALB/c and MIF-deficient mice (4 mice per group for each 229 
condition).  230 
Total RNA from tissues was extracted by firstly placing tissue in RLT buffer (Invitrogen) and 231 
then homogenized using a Tissue Lyser II (Qiagen) set for 2 min at 25 Hz. RNA isolation was 232 
performed with the RNeasy mini kit (Qiagen) according to manufacturerÕs instructions. RNA 233 
amplification and biotinylation prior to array hybridisation was performed using the Illumina 234 
TotalPrep RNA Amplification kit (Ambion) according to manufacturerÕs instructions. All 235 
samples were checked for RNA quality prior to hybridization by Agilent 2100 Bioanalyzer 236 
(Agilent). 237 
Data were generated at the Wellcome Trust Clinical Research Facility (WTCRF) located at 238 
Western General Hospital, Crewe Road South, Edinburgh, EH4 2XU. A total of 48 Illumina 239 
MouseWG6_V2_0_R3_11278593_A arrays were QC analysed using the arrayQualityMetrics 240 
Bioconductor package to identify sub-standard and/or outlier arrays. Three arrays were identified 241 
as outliers and were removed from subsequent analyses. 242 
Software and statistics  243 
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All statistical analyses were performed using Prism (Graphpad Software Inc.).  Error bars on 244 
graphs display mean and standard error the mean (SEM).  StudentÕs t test was used to compare 245 
groups. n.s. = not significant, * = p<0.05, ** = p<0.01, *** = p<0.001.  Results are combined 246 
from several similar experiments unless otherwise stated in the figure legend. 247 
  248 
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Results  249 
Abated anti-helminth immunity in the absence of MIF 250 
A widely used model system for helminth infection is that of H. polygyrus in which parasitic 251 
larvae invade the intestinal tract and mature to luminal-dwelling adult worms releasing eggs into 252 
the environment [25; 26].  BALB/c mice are initially susceptible to infection but are able to 253 
gradually reduce their worm load over several weeks through a macrophage-dependent 254 
mechanism [7] , and are almost fully clear of adult worms (Fig. 1 A) and fecal eggs  (Fig. 1 B) 255 
by day 28 post-infection. We tested MIF-deficient BALB/c mice and found that they were 256 
unable to reduce adult worm burdens or egg output following a primary H. polygyrus infection. 257 
We then tested resistance of MIFÐ/Ð mice to parasite infection in two models of acquired 258 
immunity. In the first, immunity to infection can be accelerated by a prior episode of abbreviated 259 
infection, terminated by anthelmintic therapy [27]; in this case, alternatively-activated (M2) 260 
macrophages have been shown to be essential for protection [28]. We found that MIF-deficient 261 
mice are unable to expel adult worms, which are mostly cleared by day 21 in the wild-type mice 262 
(Fig. 1 C). Secondly, we used a vaccine model in which sterilizing immunity is elicited by 263 
immunization with H. polygyrus excretory-secretory (ES) products in alum adjuvant [24]. In this 264 
setting, BALB/c mice show complete protection but MIF-deficient animals fail to clear the 265 
parasites (Fig. 1 D).  266 
We also reproduced the phenotype using a pharmacological inhibitor of MIF, 4-iodo-6-267 
phenylpyrimidine (4-IPP), which acts as a "suicide substrate" by covalently binding the N-268 
terminal proline required for catalytic activity [17; 22]. Mice receiving this inhibitor showed 269 
significantly greater susceptibility than vehicle-treated mice to H. polygyrus, in terms of both 270 
adult worm burdens and egg output (Fig. 1 E, F).  271 
Although immunity generally correlates with the formation of intestinal granulomas [29; 30], we 272 
found that MIF
Ð/Ð
 mice developed normal numbers of granulomas despite being completely 273 
susceptible to infection (Fig. 1 G).   274 
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Intact adaptive Type 2 responses in MIF-deficient mice 275 
Immunity to H. polygyrus following either drug-mediated clearance, or HES vaccination, has 276 
been shown to be antibody-dependent, in particular requiring IgG1 [24; 31]. We therefore 277 
compared serological responses to infection in wild-type and MIF
Ð/Ð
 mice but found no 278 
difference in serum IgG1 titer (Fig. 2 A). In addition, both genotypes responded with equally 279 
high anti-HES antibody titers following vaccination (Fig. 2 B), although only the MIF
Ð/Ð
 animals 280 
failed to expel parasites. These findings implicated a deficiency in the cellular arm of the 281 
response in the absence of MIF. 282 
We then compared parasite-specific T cell responses, as immunity to H. polygyrus is strongly 283 
Th2 dependent [32], by challenging small intestine draining mesenteric lymph node (MLN) cells 284 
from H. polygyrus-infected BALB/c and MIF
Ð/Ð
 mice with HES antigens. We found comparably 285 
robust IL-4 and IL-13 responses in both strains (Fig. 2 C, D); no induction of antigen-specific 286 
IFNγ responses above background was seen in either strain (data not shown), indicating the 287 
susceptibility of the MIF-deficient mouse cannot be explained by a switch to the Th1 mode of 288 
immunity.  289 
Regulatory T cells (Treg) expressing the Foxp3
+
 transcription factor are known to expand during 290 
H. polygyrus infection [33; 34] and render mice susceptible [35; 36]. MLN cell populations were 291 
analyzed by flow cytometry at 14 and 28 days post-infection, and similar increases in Foxp3
+
 292 
Treg numbers were seen in both wild-type and MIF
-/-
 mice infected with H. polygyrus (Fig. 2 E). 293 
Increases in Treg frequency (as percentage of total CD4
+
 cells) and Foxp3 intensity were also 294 
simlar between the two strains (data not shown), indicating that increased Treg activity is not 295 
contributing to greater susceptibility in the gene-targeted mice.  296 
Impaired innate Type 2 responses in MIF-deficient mice 297 
We then analyzed innate immune cell responses in BALB/c and MIF
Ð/Ð
 mice at day 7 post-H. 298 
polygyrus infection. In the wild-type animals, infection provokes a sharp increase in cell 299 
numbers within the MLNs (Fig 3 A), which is diminished in the MIF
Ð/Ð
 mice. Infection also 300 
results in activation of ILC2s to express IL-5 which is almost totally ablated in the MIF-deficient 301 
animals (Fig. 3 B). Notably, while the proportion of ILCs within the lymph nodes of both 302 
genotypes are similar, fewer are IL-5
+
 (Fig 3 C). Likewise, cellular expansion in the peritoneal 303 
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cavity provoked by infection is profoundly reduced in MIF-deficient mice (Fig. 3 D), as is 304 
eosinophilia (Fig. 3 E). The loss of eosinophils in the absence of MIF has previously been 305 
observed in both helminth infection and airway asthma models [13; 37; 38]. We also tested the 306 
MIF-dependence of eosinophilia by administering the 4-IPP MIF inhibitor at the time of H. 307 
polygyrus infection. Wild-type mice receiving this inhibitor showed significantly reduced 308 
peritoneal eosinophilia compared to animals treated with the DMSO vehicle alone (Fig. 3 F).  309 
To ascertain whether ILC2 differentiation was intrinsically compromised in MIF-deficient mice, 310 
we first tested the effects of exogenous IL-33 injection on the activation of ILCs in the lung; IL-311 
33 drove equivalent IL-5
+
 ILC2 responses irrespective of MIF genotype  (Fig. 3 G). We then 312 
tested the response of mice to airway challenge with Alternaria allergen, a potent stimulator of 313 
the ILC2 population through provoking rapid release of IL-33 from the airway epithelium [39]. 314 
The introduction of exogenous Alternaria antigen elicited equivalent levels of IL-33 into the 315 
bronchoalveolar lavage after 1 hr in BALB/c and MIF-deficient animals (Fig. 3 H), arguing that 316 
both the release of ILC2-stimulating alarmins and the development of ILC2 responses to these 317 
cytokines are intact in the MIF-deficient setting. 318 
The diminished eosinophil responses in MIF-deficient mice cannot readily account for their 319 
increased susceptibility, as eosinophil-deficient ΔdblGATA mice retain their ability to expel H. 320 
polygyrus following vaccination [24].  In addition, the poor ILC2 response observed did not 321 
translate into any shortfall in the Th2 response that develops to parasite antigens (Fig. 2 C, D), 322 
although it is possible that abated ILC2 production of IL-5 explains the deficient eosinophil 323 
responses in MIF
Ð/Ð
 mice. 324 
Type 2 myeloid responses in MIF-deficient mice 325 
We next analyzed myeloid subpopulations, which play critical roles in mediating immunity in 326 
many helminth settings [7; 28; 40]. To establish whether the absence of MIF resulted in 327 
significant differences within the myeloid compartment, we compared the phenotype of CD11b
+
 328 
F4/80
+ 
macrophages in MIF-sufficient and -deficient mice. We found that, following H. 329 
polygyrus infection, few viable lamina propria cells could be recovered from either BALB/c or 330 
MIF-deficient mice and hence populations were assayed from the peritoneal cavity, in which 331 
there is extensive expansion and alternative activation of macrophages during the first week of 332 
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infection [41]. Notably, the increase in macrophage numbers was muted in the peritoneal cavity 333 
of MIF-deficient mice (27% above nave levels) compared to wild-type animals (90% increased) 334 
(Fig. 4 A).  335 
Because MIF has previously been shown to promote the alternative activation of macrophages, 336 
alongside IL-4Rα-binding cytokines [16], we measured expression of key alternatively-activated 337 
macrophage (AAM)-associated gene products Arginase-1, Chil3 (Ym1) and RELMα by a 338 
combination of flow cytometry of peritoneal cell populations, and ELISA for soluble proteins in 339 
peritoneal lavage fluids. By each of these measures MIF
Ð/Ð
 mice showed significant impairment 340 
of alternative activation. Thus, the proportions of peritoneal macrophages staining for Arginase-1 341 
(Fig. 4 B, C) and RELMα (Fig. 4 D, E) were significantly reduced in MIF-deficient animals, as 342 
were levels of detectable Chil3 and RELMα protein in the lavage following H. polygyrus 343 
infection (see below). 344 
We next examined the in vivo effects of pharmacological MIF inhibition on the expression of 345 
AAM markers; administration of 4-IPP significantly reduced the number of CD11b
+
 Arginase-1
+
 346 
(Fig. 4 F) and Chil3
+
 (Fig. 4 G) peritoneal macrophages after H. polygyrus infection, as well as 347 
the levels of both Chil3 and RELMα protein in the peritoneal lavage fluid of BALB/c mice (Fig. 348 
4 H). 349 
To test whether MIF is directly responsible for the alternative activation of macrophages, we 350 
evaluated the effects of administering recombinant MIF into the peritoneal cavity of MIF-351 
deficient mice. Such treatment restored the proportions of Chil3
+
 AAM in this site after H. 352 
polygyrus infection to levels comparable with wild-type mice (Fig. 5 A), but did not rescue the 353 
significant deficit in ILC2 cells in the same location (Fig. 5 B).  Exogenous MIF was able to 354 
partially restore protein levels of Chil3 and RELM-α in the peritoneal lavage fluid of MIF
-/-
 mice 355 
(Fig. 5 C, D), although remaining significantly below those of the wild-type mice, and no 356 
eosinophilia was elicited (data not shown). Furthermore, these products were also upregulated in 357 
small intestinal tissues of H. polygyrus-infected MIF-deficient mice (Fig. 5 E, F). As 358 
intraperitoneal delivery of MIF did not restore resistance to the parasite infection (data not 359 
shown), it is likely that localized production and release within the intestinal tract may be 360 
required for effective recruitment and activation of tissue macrophages at the site of infection. 361 
In revi
ew
Filbey et al.  Page 16 
While peritoneal macrophages may mirror the phenotype of the intestinal population, it is 362 
important to also study those cells closely associated with larval parasites in the submucosa of 363 
the small intestine, where H. polygyrus is found for the first 8 days of infection. We used 364 
immunofluorescence imaging to characterise the patterns of macrophage activation and 365 
accumulation around larval parasites, and their expression of Arginase-1 which is known to be 366 
required for immunity to this helminth [28]. Surprisingly, local macrophage infiltration and 367 
overall Arginase-1 expression did not significantly differ in infected MIF
Ð/Ð
 mice (Fig. 6 A), and 368 
although the intensity of Arginase-1 staining in gene-deficient tissues was marginally weaker at 369 
day 4 of infection  (Fig. 6 B), by day 6 it was as ubiquitous as in the wild-type controls (Fig. 6 370 
C).  In both examples, Arginase-1 is disseminated throughout the granuloma, indicating that it is 371 
either or both expressed by cells other than macrophages, and/or released extensively into the 372 
extracellular milieu from those cells which express it.  Immunohistochemical staining was also 373 
used to identify widespread expression of MIF in intestinal tissues in vivo; in particular, MIF was 374 
intensely expressed within the granulomas centered around immobile larvae (Fig. 6 D), at the 375 
foci of the local immune response to intestinal helminth infection. 376 
Gene expression in H. polygyrus-infected MIF-deficient mice 377 
To gain insight into possible signaling and effector molecules dependent upon MIF in helminth 378 
infection, we compared gene expression profiles of MIF-sufficient and Ðdeficient mice by array 379 
analyses of duodenal tissue taken 3, 5 and 7 days following H. polygyrus infection, as well as 380 
MLN sampled on day 5. As shown in Fig. 7 A, B, relatively few genes showed major expression 381 
changes but among them were Arl2bp, a little-studied gene encoding a protein which stabilizes 382 
nuclear localization of the STAT3 transcription factor [42], and Phc2, a central component of the 383 
Polycomb 1 complex that maintains epigenetic imprinting [43]. In addition, a number of other 384 
genes showed either smaller or more transient reductions in levels in H. polygyrus-infected MIF
-
385 
/-
 mice compared to wild-type, including Retnlb (encoding RELM-β) and Pla2g1b, two 386 
epithelial-expressed genes reported to possess direct anti-helminth properties [44; 45]. 387 
STAT3 signaling contributes to immunity to H. polygyrus 388 
Gene expression differences for Arl2bp and Phc2 were confirmed by RT-PCR on MLN samples 389 
at day 5 of infection of wild-type and MIF-deficient mice (Fig. 7 C, D). As abated Arl2bp 390 
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expression may compromise STAT3 signaling, we then tested mice in which STAT3 expression 391 
had been blocked in myeloid lineages through transgenic expression of Cre recombinase under 392 
the LysM promoter, combined with homozygous alleles for a flox-flanked STAT3 [46]. We first 393 
examined CD11b
+
F4/80
+
 peritoneal macrophages from H. polygyrus-infected mice, and found 394 
significantly fewer cells expressed intracellular Arginase-1 in mice carrying the myeloid-395 
restricted deletion (Fig. 8 A); notably, Chil3+ cell numbers were similar, albeit low, in both 396 
genotypes (Fig. 8 B). We also collected peritoneal lavage fluid, and found significantly lower 397 
Arginase enzymatic activity in the STAT3-conditionally deleted mice (Fig. 8 C). In addition, we 398 
measured soluble Chil3 in the lavage fluid, which rather than being inhibited in mice lacking 399 
myeloid cell STAT3 expression, actually showed a significant increase (Fig. 8 D). 400 
As the C57BL/6 background is fully susceptible to primary H. polygyrus infection, we then 401 
evaluated immunity to a secondary challenge with H. polygyrus following chemotherapeutic 402 
clearance of the primary infection.  In wild-type mice lacking the Cre allele, there was significant 403 
protection against challenge, but in myeloid-specific STAT3-deleted animals, parasite loads were 404 
similar in primary and secondary infection, showing a failure of protective immunity in the 405 
STAT3-deficient setting (Fig.8 E). 406 
  407 
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Discussion 408 
The crucial role of innate immune cell populations in immunity to helminths is well recognized 409 
[5; 47], but the molecular mediators required for their activation have not all been identified. 410 
Here we report that MIF is a critical cytokine required for clearance of the intestinal parasite H. 411 
polygyrus, impacting on multiple type 2 innate cell populations while not significantly affecting 412 
adaptive B or T cell responses. Although previously viewed as a pro-inflammatory agent in 413 
settings of sepsis and microbial challenge [48], our work and that of others demonstrate that its 414 
role is context-dependent, so that in the presence of the pivotal type 2 cytokine IL-4, MIF will 415 
synergise to induce characteristic M2 products including Chil3, RELMα and Arginase-1 [16; 416 
17]. Significantly, the activity of MIF is not confined to the macrophage lineage, with evident 417 
lesions in ILC numbers, and a profound loss of eosinophils, in MIF-deficient animals. These 418 
multiple facets of MIF are characteristic of a protein with a range of diverse activities that are 419 
remarkable for a protein of only 114 amino acids, and one discovered at the dawn of the cytokine 420 
era [49; 50]. For example, MIF is also a nonconsensus ligand of chemokine receptors [51], an 421 
inhibitor of intracellular signaling and inflammasome assembly [52; 53] and a partner in a 422 
nuclear DNA-cleaving complex [54].   423 
Immunity to H. polygyrus is known to require a potent type 2 response, dependent upon CD4
+
 424 
Th2 cells driving a specific IgG1 antibody response together with alternatively-activated (M2) 425 
macrophages stimulated through the IL-4R [7; 28; 55].  Immunity can act in two distinct phases: 426 
firstly against tissue-dwelling larvae which are immobilised and killed in the setting of a 427 
challenge infection or an immunized host, and secondly against luminal adults which are cleared 428 
by the combined action of activated myeloid and epithelial cells [26]. Importantly, parasites 429 
surviving immune attack in the tissues can emerge into the lumen with diminished fitness, 430 
resulting in lower egg production and shorter survival times.  MIF deficiency was found not only 431 
to compromise worm expulsion in both naive and vaccinated animals, but also to result in 432 
significantly higher egg production at day 14 (Fig 1 B), confirming that early responses to the 433 
tissue larvae are abated in the absence of MIF. 434 
Among other innate cell populations, ILC2s can promote the response, but are not sufficient for 435 
expulsion [56], while eosinophils act to restrain the intestinal Th2 response to H. polygyrus [57] 436 
In revi
w
Filbey et al.  Page 19 
and eosinophil-deficient mice clear parasites promptly following immunization with a secreted 437 
antigen vaccine [24]. As MIF-deficient mice mounted a normal adaptive B- and T cell response 438 
to infection, we concluded that these mice must lack a key innate effector population, which we 439 
propose are the IL-4R-dependent M2 macrophages. Indeed, even in the presence of memory Th2 440 
cells known to drive M2-dependent immunity to H. polygyrus [28] immunity fails in the absence 441 
of MIF, again suggesting lesion(s) in the macrophage compartment.  If so, this would argue that 442 
IL-4R ligation may require supplementation through other signals to achieve the fully activated 443 
M2 state required for worm expulsion. A further interesting point is that MIF-deficient mice 444 
generated a similar granuloma response to wild-type animals, and yet could not trap parasites 445 
even following vaccination. As cell recruitment to granulomas was similar in the two genotypes, 446 
and as MIF itself is highly expressed in the WT granuloma, it may be that MIF acts not at the 447 
level of differential cell recruitment, but by activating cells locally to promote immunity. 448 
It is known that numbers of macrophages in H. polygyrus infection rapidly expand, notably in 449 
the peritoneal cavity, and adopt the M2 phenotype characterized by production of Arginase-1, 450 
Chil3 and RELMα [41].  We noted a significant delay in peritoneal macrophage activation in 451 
MIF-deficient animals, with a lag also evident in production of these archetypal markers, 452 
although the effect was less obvious at the tissue site of infection. However, it is known that 453 
genetically resistant strains of mice mount a more rapid response to H. polygyrus [7], suggesting 454 
that retardation of M2 activation in the absence of MIF may account for failure of immunity.   455 
We further established the role of MIF in testing a pharmacological inhibitor, which 456 
recapitulated both impaired expression of M2 gene products, and greater susceptibility to 457 
infection, that are observed in the gene-targeted mice. In addition, we established exogenous 458 
MIF could restore the activation of peritoneal macrophages to the wild-type profile. 459 
Previous work has demonstrated that immunity to H. polygyrus is compromised by clodronate 460 
depletion of macrophages [7], and by pharmacological blockade of arginase-1, a principal 461 
product of M2 macrophages [28]. However, we have yet to establish whether such macrophages 462 
activated by MIF would be sufficient to confer immunity by adoptive transfer to naive recipients. 463 
One obstacle to such an experiment is that appropriate migration of the adoptively transferred 464 
population to the site of infection may not occur, particularly given that MIF is thought to arrest 465 
macrophage migration in situ. We note, however, that in a related parasite model of 466 
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Nippostrongylus brasiliensis, in which larvae transit the lung intranasal transfer of M2 467 
macrophages significantly augments anti-parasite immunity [58]. 468 
To further analyse the role of MIF in vivo, we next compared gene expression profiles, in the 469 
intestinal tract and MLN.  In these tissues, disparities in M2 macrophage products were not so 470 
apparent, but two transcripts markedly under-represented in the MIF-deficient state were Arl2bp 471 
and Phc2.  The former is a STAT3 nuclear retention factor, raising the possibility that STAT3 is 472 
required for functional macrophage activity in H. polygyrus infection. While we did not observe 473 
any difference in STAT3 phosphorylation following IL-6 or IL-10 stimulation of wild-type or 474 
MIF-deficient cells (data not shown), Arl2bp may manifest a more subtle effect on nuclear 475 
activity which we could not detect.  However, it has previously been shown that Arginase-1 and 476 
Chil3 expression are STAT-3 dependent in mammary epithelial cells [59], as is also the case for 477 
Arginase-1 in myeloid-derived suppressor cells (MDSCs) [60], which share some characteristics 478 
with M2 macrophages.  Although global STAT3 deletion is lethal in mice, we were able to test 479 
animals with a myeloid-specific conditional deletion of STAT3, which show modest reduction in 480 
Arginase-1 expression during H. polygyrus infection and lose the ability to expel parasites on 481 
secondary exposure.  As pharmacological inhibition of arginase is also able to block expulsion of 482 
this parasite [28], these data may indicate that small changes in the timing or peak of arginase 483 
production are sufficient to alter the outcome of infection. In addition, our finding that Chil3 is 484 
actually increased in myeloid-specific STAT3-deficient mice which fail to expel, would argue 485 
that despite its abundance, Chil3 is not a primary factor that promotes helminth clearance. 486 
As mentioned above, MDSCs commonly express arginase. They are also expanded in vitro by 487 
MIF [17; 61; 62], and their development is in part STAT3-dependent [63]. Furthermore, MDSC 488 
transfer alone has been reported to hasten expulsion of the nematode species N. brasiliensis from 489 
mice [64]. In addition, key enzymes such as amylases (Amy2a5, Fig. 7 B) which show ablated 490 
gene expression in MIF-deficient mice are reported to be up-regulated in tumor-associated 491 
MDSCs [65]. However, MDSCs are a highly heterogenous grouping of myeloid cells [66], and 492 
further definition of which, if any, subset of these cells may play a role in helminth immunity 493 
will be an important future goal. 494 
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While our data argue that MIF, and STAT3, are each involved in macrophage immune function, 495 
we cannot exclude that other cell types respond to these signals, and are integrally required for 496 
parasite expulsion. For example, neutrophils play a role particularly in primary infection, as 497 
depletion of Gr1
+
 cells compromises primary immunity to H. polygyrus [24; 67] and can prime 498 
macrophages for resistance to challenge infection with this parasite [68].  499 
Finally, in mice lacking MIF there was a substantial reduction of a polycomb 1 complex gene, 500 
Phc2, which we are now exploring. The polycomb complex mediates chromosomal imprinting 501 
[43] which is a central feature of macrophage commitment and innate immune memory [69; 70; 502 
71]. While Phc2 itself has yet to be implicated in macrophage differentiation, other polycomb 503 
components are known to be involved  [72], and epigenetic modifications have been found to be  504 
essential to the phenotypes of both M1 [73; 74] and M2 [75; 76] macrophages. Hence, there may 505 
be a longer-term inability of macrophages to fully polarize and form innate memory in the 506 
absence of MIF, which in turn could explain the failure to expel parasites in vaccinated animals. 507 
With this report, MIF may be seen as joining the ranks of intestinal epithelial-derived mediators 508 
that recruit and sustain innate immune responses. However, MIF is produced and functions in  509 
many niches, and many critical features underpinning the source, stimulus and regulation of its 510 
expression remain to be determined. The discovery that additional stimuli are required for 511 
optimal alternative activation will also be important in defining the pathway through which the 512 
M2 phenotype is controlled. Indeed, a number of co-activating pathways for M2 macrophages 513 
have very recently been described including surfactant protein A [77] and markers of apoptosis 514 
[78] Ð as with MIF these ligands may prove indispensable in designing future interventions to 515 
generate protective immunity to the range of parasitic organisms for which type 2 immunity is 516 
critical. 517 
  518 
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FIGURES AND FIGURE LEGENDS 803 
Figure 1 - Compromised anti-helminth immunity in the absence of MIF 804 
A, B.  Differential susceptibility of BALB/c and MIF
-/-
 mice to primary infection with H. polygyrus.  805 
Adult worm burdens in the small intestine (A) and fecal egg counts (B) were determined at 806 
days 14 and 28 post-infection with 200 H. polygyrus larvae by gavage. Data shown are 807 
combined from 3 independent experiments. 808 
C.  Differential induction of immunity following drug-abbreviated primary infection in BALB/c 809 
and MIF
-/-
 mice. At day 28 following infection with H. polygyrus, mice were given 2.5 mg of 810 
pyrantel embonate by oral gavage, twice over 24 hours.  After a further 14 days, mice were 811 
reinfected (or infected for the first time in 1¡ groups).  Adult worms were enumerated at day 21 812 
post infection.  Data shown are combined from 2 independent experiments. 813 
D. Differential expression of vaccine-induced immunity in BALB/c and MIF
Ð/Ð
 mice. At day 0, 814 
mice were injected with 10 µg of HES in alum, or PBS-alum control, followed by booster 815 
injections of 1 µg HES or PBS at days 28 and 35. On day 42 all mice were infected with H. 816 
polygyrus.  Adult worm burdens were counted at day 21 post-infection. Data shown are 817 
combined from 2 independent experiments.  818 
E, F.  The MIF inhibitor 4-iodo-6-phenylpyrimidine (4-IPP) inhibits immunity in BALB/c mice 819 
infected with H. polygyrus.  1 mg 4-IPP in DMSO or DMSO alone was injected i.p. at days -1, 820 
0, 2, 4 and 6 post-infection.  Adult worms (F) and egg burdens (G) were enumerated at day 28 821 
post-infection. Data shown are combined from 2 independent experiments.  822 
G. Numbers of intestinal granulomas in BALB/c and MIF
-/-
 mice 14 days following primary 823 
infection with H. polygyrus. Data shown are combined from 2 independent experiments.  824 
n.s. = not significant, * = p<0.05, *** = p<0.001, **** = p<0.0001    825 
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 826 
Figure 2 - Intact adaptive and regulatory responses in MIF-deficient mice 827 
A.  Comparable anti-helminth humoral immunity in BALB/c and MIF
-/-
 mice.  Titers of HES-828 
specific IgG1 serum antibodies from nave and day 28-infected BALB/c and MIF
-/-
 mice, 829 
assesed by ELISA.  Data are representative of two independent experiments. 830 
B. Comparable anti-helminth humoral immunity in HES-vaccinated BALB/c and MIF
-/-
 mice. 831 
Parasite-specific antibody responses in vaccinated BALB/c and MIF
Ð/Ð
 mice. HES-specific 832 
serum IgG1 levels were measured by ELISA on the day of challenge infection. Data are 833 
representative of two independent experiments. 834 
C, D. Comparable adaptive type 2 immune responses in BALB/c and MIF
-/-
 mice.  Th2 cytokines 835 
from culture medium of MLNC from nave and day 14 H. polygyrus-infected BALB/c and 836 
MIF
-/-
 mice, restimulated with 1 µg/ml HES or media for 72 hours.  Levels of IL-4 (C) and IL-837 
13 (D) were measured by ELISA.  Data are representative of two independent experiments. 838 
E. Regulatory cell induction by helminth infection is comparable between BALB/c and MIF
-/-
 839 
mice.  Numbers of CD4
+
Foxp3
+
 Treg cells within MLNs from BALB/c and MIF
-/-
 mice at 840 
days 14 and 28 post-infection with H. polygyrus. Data are representative of two independent 841 
experiments. 842 
n.s. = not significant, ** = p<0.01, *** = p<0.001 843 
844 
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Figure 3 - Impaired innate type 2 responses in MIF-deficient mice 845 
A.  Total numbers of MLN cells recovered from BALB/c and MIF
-/-
 mice 7 days following H. 846 
polygyrus infection. Data are representative of two independent experiments. 847 
B. Differential induction of ILC2s in BALB/c and MIF
-/-
 mice following H. polygyrus infection. 848 
Total numbers of IL-5
+
 ICOS
+
 lineage
Ð
 ILC2s within MLNC from nave and d7 H. polygyrus-849 
infected BALB/c and MIF
-/-
 mice.  Data are representative of two independent experiments.  850 
C. Representative flow cytometry plots of ICOS vs Lineage markers within CD4
-
 MLN cells from 851 
nave BALB/c and MIF
-/-
 mice or 7 days following H. polygyrus infection. 852 
D.  Total numbers of peritoneal lavage cells recovered from BALB/c and MIF
-/-
 mice 7 days 853 
following H. polygyrus infection. Data are representative of two independent experiments. 854 
E. Differential induction of eosinophilia in BALB/c and MIF
-/-
 mice following H. polygyrus 855 
infection. Total numbers of eosinophils (SiglecF
+
 CD11b
+
) in nave and H. polygyrus-infected 856 
BALB/c or MIF
-/-
 mice within the peritoneal lavage, at day 7 post-infection. Data are 857 
representative of two independent experiments.   858 
F. The MIF inhibitor 4-IPP inhibits eosinophilia in BALB/c mice infected with H. polygyrus. 859 
Eosinophil numbers at day 7 post-infection with H. polygyrus in BALB/c following 860 
administration of 1 mg of the MIF inhibitor, 4-IPP, assessed as SiglecF
+
CD11b
+
 cells within 861 
the peritoneal lavage. Results are combined from two experiments with similar results.  862 
G. MIF
-/-
 mice do not have an intrinsic defect in ILC2 induction.  IL-5
+
 ILC2s as a proportion of 863 
live cells in digested lung tissue of BALB/c or MIF
-/- 
mice treated intranasally with PBS or rIL-864 
33, measured by flow cytometry. Data are representative of two independent experiments, and 865 
were analyzed by nonparametric statistics. 866 
H. MIF
-/-
 mice have normal ability to release the key alarmin IL-33 upon stimulation.  Levels of 867 
IL-33 in BALF of BALB/c or MIF
-/- 
mice 1 hour after intranasal administration of 10 µg 868 
Alternaria antigen, measured by ELISA. Results are combined from two experiments with 869 
similar results.  870 
n.s. = not significant, *=p<0.05, ** = p<0.01, *** = p<0.001 871 
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Figure 4 - Type 2 myeloid responses in MIF-deficient mice 873 
A.   MIF
Ð/Ð
 mice have a reduced capacity for induction of macrophages after helminth infection. 874 
Total macrophage (CD11b
+
F4/80
+
) numbers within the peritoneal cavity of BALB/c and MIF
Ð
875 
/Ð
 mice at day 6 post-infection with H. polygyrus, or in nave mice.  Data are representative of 876 
two independent experiments.   877 
B.   Percentage of peritoneal macrophages that are Arginase
+ 
in BALB/c and MIF
Ð/Ð
 mice at day 3 878 
post-infection with H. polygyrus, or in nave mice. Results are combined from two experiments 879 
with similar results.   880 
C.  Representative flow cytometry plots of CD11b and Arginase-1 staining in peritoneal 881 
macrophages from BALB/c and MIF
Ð/Ð
 mice. 882 
D.  Percentage of peritoneal macrophages that are RELMα
+ 
in BALB/c and MIF
Ð/Ð
 mice at day 6 883 
post-infection with H. polygyrus, or in nave mice (D) and . Data are representative of two 884 
independent experiments.   885 
E  Representative flow cytometry plots of CD11b and RELM-α staining in peritoneal 886 
macrophages from BALB/c and MIF
Ð/Ð
 mice.  887 
F. The MIF inhibitor, 4IPP, can replicate the macrophage deficit of MIF
-/-
 mice in BALB/c mice 888 
after H. polygyrus infection.  Percentage of peritoneal macrophages that are Arginase-1
+ 
in 889 
DMSO- or 4IPP- treated BALB/c mice at day 3 post-infection with H. polygyrus, or in nave 890 
mice receiving no treatment.  Data are representative of two independent experiments.   891 
G.   Number of peritoneal macrophages that are Chil3
+ 
in DMSO- or 4IPP-treated BALB/c mice at 892 
day 7 post-infection with H. polygyrus. Results are combined from two experiments with 893 
similar results.  894 
H.  Levels of RELMα and Chil3 measured by ELISA in peritoneal lavage fluid of DMSO- or 895 
4IPP- treated BALB/c mice at day 7 post-infection with H. polygyrus. Data are representative 896 
of two independent experiments.   897 
*=p<0.05, ** = p<0.01, *** = p<0.001 898 
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Figure 5 Ð rMIF rescues the macrophage phenotype of MIF-deficient mice 900 
A. Administration of recombinant MIF can rescue the MIF
-/-
 phenotype after H. polygyrus 901 
infection.  Percentage of peritoneal macrophages (CD11b
+
 F4/80
+
) that are Chil3
+ 
in BALB/c 902 
or MIF
-/-
 mice treated with PBS or 50 µg recombinant MIF intraperitoneally, at day 7 post-903 
infection with H. polygyrus, or in nave mice.  Results are combined from two experiments 904 
with similar results.  905 
B. Percentage of PL cells that are IL-5
+
 ILC2s from the same experiments as (A).  Results are 906 
combined from two experiments with similar results.  907 
C, D. Expression of Chil3 (C) and RELMα (D) in peritoneal lavage fluid, measured by ELISA, from 908 
the same experiments as (A).  Results are combined from two experiments with similar results.  909 
E, F.  Expression of Chil3 (E) and RELMα (F) in small intestinal homogenate, measured by ELISA, 910 
from the same experiments as (A).  Results are combined from two experiments with similar 911 
results.  912 
n.s. = not significant, * = p<0.05, ** = p<0.01, *** p=<0.001. 913 
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Figure 6 - Myeloid cell infiltration around tissue larvae of H. polygyrus with expression of 915 
Arginase-1 and MIF  916 
A. M2 macrophages infiltrate the infection site of H. polygyrus larvae in the small intestine.  917 
Arginase, CD68 and EpCam staining of granulomas around larval parasites in the small 918 
intestinal submucosa at days 4 and 6 of H. polygyrus infection in BALB/c and MIF
Ð/Ð
 mice. 919 
Images are representative of two experiments with similar results. 920 
B, C. Analysis of intensity of Arginase staining in granulomas at days 4 and 6 after H. polygyrus 921 
infection. For each group at each time point, granulomas were analyzed from 4 individual 922 
animals, and intensity data pooled.  Each data point represents an individual granuloma. 923 
D.  MIF is expressed in the infection site of H. polygyrus larvae in the small intestine. Intense 924 
staining of polyclonal rabbit anti-MIF antibody is observed in the granulomas around larval 925 
parasites in the small intestinal submucosa at day 6 of H. polygyrus infection in BALB/c mice, 926 
but not in MIF
Ð/Ð
 animals or in sections stained with isotype control IgG. In addition, 927 
widespread specific antibody staining is seen throughout the submucosal tissue. Images were 928 
collected on a Leica compound microscope. Scale bars represent 500 and 250 µm. 929 In rev
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Figure 7 - Gene expression in H. polygyrus-infected MIF-deficient mice 930 
A. Volcano plot comparing gene expression in duodenal tissue from BALB/c and MIF
-/-
 mice 5 931 
days after H. polygyrus infection.  Genes of interest are labeled in red; other loci showing large 932 
and/or significant changes are labeled in blue.  933 
B. Heat maps from two gene expression experiments, on duodenal and MLN tissue for expression 934 
of selected genes 5 days after H. polygyrus infection in BALB/c and MIF
-/-
 mice (left hand 935 
panel), and of duodenal tissues at days 3 and 5 post-infection in the same genotype mice (right 936 
hand panel).  Expression levels are colored from blue (lowest) to yellow(highest) and in each 937 
case represent the mean of 4 replicates. 938 
C, D. RT-PCR validation of Arl2bp (C) and Phc2 (D). MLNs were harvested for analysis at d 5 of H. 939 
polygyrus infection, and subject to RT-PCR using gene specific primers. 940 
hima 941 
  942 
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Figure 8 - Myeloid cell expression of STAT3 is required for optimal Arginase-1 expression and 943 
for secondary immunity to H polygyrus 944 
A.  Peritoneal macrophages were recovered from conditional STAT3 gene deleted and control 945 
mice, with genotypes of STAT3
fl/fl
xLysM
Cre/Ð
 and STAT3
fl/fl
xLysM
Ð/Ð
  respectively, and stained 946 
for surface CD11b and F4/80, together with intracellular Arginase -1. Staining was evaluated 947 
by flow cytometry.  Data are pooled from three independent experiments. * = p<0.05. 948 
B.  Expression of Chil3 within the same macrophage populations. Data are pooled from three 949 
independent experiments. n.s. = not significant. 950 
C Peritoneal lavage fluids were recovered from the same animals as in A and B, and functional 951 
soluble arginase levels measured by an enzyme assay. * = p<0.05. 952 
D. Presence of Chil3 protein in the same lavage fluids as C. * = p<0.05. 953 
E.  Myeloid cell-specific deletion of STAT3 impairs secondary immunity. LysM
Cre
xSTAT3
fl/fl
 954 
mice and STAT3
fl/fl
 controls) were infected with H.  polygyrus and infections cleared with 955 
pyrantel embonate.  Mice were subsequently challenged with a secondary infection, or infected 956 
for the first time for primary controls, and adult worms counted in the small intestine at d21 957 
post infection.  Results are combined from two experiments with similar results.   n.s. = not 958 
significant, * = p<0.05. 959 
 960 
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